105166-45-8 Usage
Chemical structure
The compound has a complex structure with a benzazepin ring system and a tetrahydro-1-methyl-3-(phenylmethyl)moiety.
Molecular weight
The molecular weight of the compound is approximately 309.42 g/mol.
Pharmacological properties
Due to its structural features, the compound is likely to exhibit pharmacological properties, making it potentially suitable for use in medicinal or research applications.
Further analysis and experimentation
To fully understand the potential uses and effects of the compound, further analysis and experimentation are necessary.
Solubility
The solubility of the compound in various solvents is not provided in the material, but it is likely to be influenced by its molecular structure and functional groups.
Stability
The stability of the compound under different conditions (e.g., temperature, pH, light exposure) is not provided in the material, but it may be affected by its molecular structure and functional groups.
Reactivity
The reactivity of the compound with other chemicals or under specific conditions is not provided in the material, but it may be influenced by its molecular structure and functional groups.
Synthesis
The synthesis method for the compound is not provided in the material, but it may involve the formation of the benzazepin ring system and the attachment of the tetrahydro-1-methyl-3-(phenylmethyl)moiety.
Applications
The potential applications of the compound in the fields of medicine, pharmaceuticals, or research are not provided in the material, but they may be related to its pharmacological properties and structural features.
Check Digit Verification of cas no
The CAS Registry Mumber 105166-45-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,5,1,6 and 6 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 105166-45:
(8*1)+(7*0)+(6*5)+(5*1)+(4*6)+(3*6)+(2*4)+(1*5)=98
98 % 10 = 8
So 105166-45-8 is a valid CAS Registry Number.
105166-45-8Relevant articles and documents
Bridged-ring Nitrogen Compounds. Part 7. Synthesis of the 1,4-Ethano-3-benzazepine Ring System
Sedgeworth, Janette,Proctor, George R.
, p. 2677 - 2688 (2007/10/02)
9-Bromobenzosuberone was converted via 9-cyanobenzosuberone into several other 9-substituted benzosuberones, but attemps to cause them to cyclise to the tricyclic 1,4-ethano-3-benzazepine ring system were unsuccessful.Both ethyl phenylacetate and ethyl 3-methoxyphenylacetate were converted by conventional procedures into the corresponding 6,7,8,9-tetrahydro-5-methyl-9,10-dioxo-5,8-methano-5H-benzocycloheptenes.The 3-methoxy derivative was further converted into N-benzyl-8-bromo-6,7,8,9-tertrahydro-3-methoxy-5-methyl-9-oxo-5H-benzocycloheptene-5-carboxamide which could be converted into the tricyclic 3-benzyl-2,3,4,5-tetrahydro-8-methoxy-1-methyl-2,5-dioxo-1,4-ethano-1H-3-benzazepine and thence in two steps into both 3-benzyl-2,3,4,5-tetrahydro-8-methoxy-1-methyl-1,4-ethano-1H-3-benzazepine and 3-benzyl-2,3,4,5-tetrahydro-8-hydroxy-1-methyl-1,4-ethano-1H-3-benzazepine.Also prepared were 3-benzyl-2,3,4,5-tetrahydro-5-hydroxy-8-methoxy-1-methyl-1,4-ethano-1H-3-benzazepine and 3-benzyl-3,4-dihydro-8-methoxy-1-methyl-1,4-ethano-1H-3-benzazepin-5(2H)-one.
